Notable 52-Week Highs and Lows 8/16: (DKS) (MOMO) (EBIO) High; (EAC) (EBS) Low

August 16, 2016 3:07 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

52-Week High:
  • Dick's Sporting Goods (NYSE: DKS) $60.40. Dick's Sporting Goods reported Q2 EPS of $0.82, which was $0.13 better than the analyst estimate of $0.69. Revenue for the quarter came in at $2 billion versus the consensus estimate of $1.88 billion. Comps rose 2.8 percent.

  • Momo (Nasdaq: MOMO) $17.48. Momo reported Q1 EPS of $0.12, versus the analyst estimate of $0.08. Revenue for the quarter came in at $99 million, versus $30.7 million reported last year.

  • Eleven Biotherapeutics, Inc. (Nasdaq: EBIO) $5.97. Eleven Biotherapeutics announced the effectiveness of the exclusive licensing deal with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. (Roche). Eleven has granted Roche an exclusive, worldwide license to develop and commercialize EBI-031 and all other IL-6 antagonist antibody technology owned by Eleven. EBI-031 is a humanized monoclonal antibody that potently binds interleukin-6 (IL-6) and inhibits all known forms of IL-6 cytokine signaling.
52-Week Low:
  • Erickson (Nasdaq: EAC) $0.48. Erickson reported Q2 EPS of ($2.81), which may not compare with the analyst estimate of ($0.64). Revenue for the quarter came in at $50.8 million versus the consensus estimate of $55 million.

  • Emergent BioSolutions Inc. (NYSE: EBS) $26.63. Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application (sBLA) for the manufacture of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55, the company’s large-scale manufacturing facility located in its 12.5-acre campus in Lansing, Michigan.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Special Reports

Add Your Comment